Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hypersensitivity to Amylin in Post-Traumatic Headache
NCT07340775Not yet recruiting
- Sponsor
- Dansk Hovedpinecenter
- Start
- Feb 2026
- Primary completion
- Dec 2028
- Modality
- Peptides
- Countries
- 1
01
Overview
Randomised, double-blind trial of pramlintide in post-traumatic headache (PTH) (2 arms), sponsored by Dansk Hovedpinecenter. Primary endpoint: Incidence of migraine-like headache at 12 hours. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
pramlintide
03
Conditions
post-traumatic headache (PTH)
Beyond the preview
Go deeper on NCT07340775.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07340775.